Vinge advises Axcel V in connection with the sale of Loopia Group to team.blue, Europe’s leading digital enabler for entrepreneurs and SMBs and backed by Hg, a leading investor in European and transatlantic software and services businesses.

Headquartered in Stockholm and with over 320 skilled professionals, Loopia Group is a leading European web service and hosting company, dedicated to sustainability and green hosting, and serving over 650,000 customers across mainly Sweden, Finland, Slovakia, Czechia, Hungary, and Serbia through a portfolio of local brands including Loopia, Websupport, Hostingpalvelu, Domainhotelli and Active24.

The transaction is subject to regulatory approvals.

Vinge’s team consisted mainly of Christina Kokko, Carl Sander, Egil Svensson and Alexander Rüdén (M&A), Marcus Glader, Sebastian Örndahl and Alva Chambert (Regulatory), Jolinn Uhlin, Ida Redander and Josef Groow (Banking and Finance), Mathilda Persson and Elis Allmark (Agreements and IT), Sam Seddigh, Narin Melazade and Jonatan Stentorp (Employment), Agnes Pigg (Real Estate), Axel Lennartsson (IP), Nicklas Thorgerzon and Siri Blomberg (GDPR), Mia Falk and Gulestan Ali (Compliance), Emy Rydén and Johanna Engström (Transaction Support Coordinators).

Read the client’s press release.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025